Yuhan Corp

Yuhan would be fourth largest pharma company in South Korea. Yuhan Corporation is a pharmaceutical and chemical firm based in South Korea. Yuhan Corp (Yuhan) develops, manufactures, and sells pharmaceutical products. APIs and intermediates for antibiotics, antivirals, antifungals, anti-thrombotic, anti-inflammatory, anti-diabetic, and antihyperlipidemics are available from the company. The company provides completed goods to treat hypertension, coronary artery disease, hyperlipidemia, cerebral thrombosis, and other disorders. Other pharmaceutical and biopharmaceutical companies can use Yuhan's custom synthesis services. It sells active pharmaceutical ingredients (API) and completed goods both domestically and internationally.

Yuhan has not only achieved one of the highest market caps and sales revenue in the Korean pharmaceutical industry, but has also been named one of the most respected and trusted companies in South Korea for 20 consecutive years, according to the Korean Management Association. Over the past 80 years, the company has succeeded in founding creed of producing the best medicines and contributing to public health through intensive research and development activities and successful collaboration with multinational pharmaceutical companies.

Yuhan has always prioritized research and development as a top corporate objective. The company approaches R&D using innovative, nimble, and translational strategies. Yuhan is able to maintain its overarching commitment to improving quality of life thanks to this three-pronged dynamic. True to the company's founding mission, Yuhan focuses its R&D efforts on developing the types of products that people require the most

Founded: 1926
Headquarters: Seoul, South Korea
Website: http://eng.yuhan.co.kr/